Literature DB >> 25373846

Investigation of (11)C-PiB equivocal PET findings.

Chisa Hosokawa1, Kazunari Ishii, Tomoko Hyodo, Kenta Sakaguchi, Kimio Usami, Kenji Shimamoto, Yuzuru Yamazoe, Makoto Hosono, Kazushi Hanada, Masami Ueda, Kazuma Saigo, Takamichi Murakami.   

Abstract

OBJECTIVE: We have encountered occasional equivocal findings when assessing cerebral cortical amyloid retention with (11)C-Pittsburgh compound B (PiB) PET. We investigated the diagnostic significance of equivocal PiB PET findings.
METHODS: This retrospective study included 101 consecutive patients complaining of cognitive disorders (30 Alzheimer's disease, 25 mild cognitive impairment, 8 Lewy body disease, 7 frontotemporal lobar degeneration, 31 others) who underwent both (11)C-PiB PET and (18)F-fluorodeoxy-D-glucose (FDG) PET. We visually classified PiB-positive, PiB-equivocal or PiB-negative ratings according to cortical uptake. For quantitative assessments of PiB PET, standard uptake values referred to cerebellar cortex (SUVR) were calculated in regional template volume of interests (frontal, temporoparietal, precuneus/posterior cingulate cortex, cerebral white matter and cerebellar cortex). The results of visual assessment were compared with the regional and mean cortical SUVRs and cortical-to-white matter ratio of PiB uptake, as well as clinical and FDG PET findings.
RESULTS: Among the 101 scans, 41 were PiB negative, 11 were PiB equivocal, and 49 were rated PiB positive in the visual assessments. The mean cortical SUVR and cortical-to-white matter ratio were 0.97 ± 0.07 and 0.57 ± 0.21 in PiB-negative, 1.51 ± 0.17 and 0.75 ± 0.06 in PiB equivocal and 2.10 ± 0.33 and 0.97 ± 0.11 in PiB-positive group, respectively. Nine of 11 subjects with PiB-equivocal findings had cognitive impairments and FDG distribution compatible with Alzheimer's disease or dementia with Lewy bodies.
CONCLUSIONS: We considered equivocal visual findings on PiB PET equivalent to PiB-positive with slight cortical uptake. In addition, slight cortical amyloid deposits were considered to cause cerebral metabolic abnormality and cognitive impairment. Although mean cortical SUVR was more sensitive than visual assessment because of low cortical-to-white matter contrast due to non-specific accumulation in white matter, it is important not to overlook small amounts of cortical uptake of PiB in visual inspection for exact diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373846     DOI: 10.1007/s12149-014-0924-8

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  7 in total

1.  The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.

Authors:  Hye Joo Son; Jungsu S Oh; Minyoung Oh; Soo Jong Kim; Jae-Hong Lee; Jee Hoon Roh; Jae Seung Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-06       Impact factor: 9.236

2.  A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort.

Authors:  Minyoung Oh; Minjung Seo; Sun Young Oh; Heeyoung Kim; Byung Wook Choi; Jungsu S Oh; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2021-03-04

3.  Topography of 11C-Pittsburgh compound B uptake in Alzheimer's disease: a voxel-based investigation of cortical and white matter regions.

Authors:  Daniele de P Faria; Fabio L Duran; Paula Squarzoni; Artur M Coutinho; Alexandre T Garcez; Pedro P Santos; Sonia M Brucki; Maira O de Oliveira; Eduardo S Trés; Orestes V Forlenza; Ricardo Nitrini; Carlos A Buchpiguel; Geraldo Busatto Filho
Journal:  Braz J Psychiatry       Date:  2018-12-06       Impact factor: 2.697

4.  Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir.

Authors:  Ida Sonni; Orit H Lesman Segev; Suzanne L Baker; Leonardo Iaccarino; Deniz Korman; Gil D Rabinovici; William J Jagust; Susan M Landau; Renaud La Joie
Journal:  Alzheimers Dement (Amst)       Date:  2020-11-28

5.  Lung carcinoma-associated cognitive impairment in a patient with Alzheimer's disease pathology: A case report.

Authors:  Kiyoto Takigawa; Masahiko Takaya; Kazunari Ishii; Kazumasa Saigoh; Osamu Shirakawa
Journal:  Clin Case Rep       Date:  2021-07-06

6.  Progressive amnestic cognitive impairment in a middle-aged patient with developmental language disorder: a case report.

Authors:  Masahiko Takaya; Kazunari Ishii; Kaori Kiguchi; Kazumasa Saigoh; Osamu Shirakawa
Journal:  J Med Case Rep       Date:  2020-09-03

7.  Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.

Authors:  Yusuke Okada; Takashi Kato; Kaori Iwata; Yasuyuki Kimura; Akinori Nakamura; Hideyuki Hattori; Hiroshi Toyama; Kazunari Ishii; Kenji Ishii; Michio Senda; Kengo Ito; Takeshi Iwatsubo
Journal:  Ann Nucl Med       Date:  2019-11-20       Impact factor: 2.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.